File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action

TitleSurveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action
Authors
KeywordsSEDRIC
Surveillance
Antimicrobial
Drug resistant infections
Epidemiology
Issue Date2018
PublisherWellcome Trust . The Journal's web site is located at https://wellcomeopenresearch.org/
Citation
Wellcome Open Research, 2018, v. 3, n. 59, p. 1-12 How to Cite?
AbstractIn recognition of the central importance of surveillance and epidemiology in the control of antimicrobial resistance and the need to strengthen surveillance at all levels, Wellcome has brought together a new international expert group SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium). SEDRIC aims to advance and transform the ways of tracking, sharing and analysing rates of infection and drug resistance, burden of disease, information on antibiotic use, opportunities for preventative measures such as vaccines, and contamination of the environment. SEDRIC will strengthen the availability of information needed to monitor and track risks, including an evaluation of access to, and utility of data generated by pharma and research activities, and will support the translation of surveillance data into interventions, changes in policy and more effective practices. Ways of working will include the provision of independent scientific analysis, advocacy and expert advice to groups, such as the Wellcome Drug Resistant Infection Priority Programme. A priority for SEDRIC's first Working Group is to review mechanisms to strengthen the generation, collection, collation and dissemination of high quality data, together with the need for creativity in the use of existing data and proxy measures, and linking to existing in-country networking infrastructure. SEDRIC will also promote the translation of technological innovations into public health solutions.
Persistent Identifierhttp://hdl.handle.net/10722/263867
ISSN
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorFukuda, K-
dc.contributor.authorLimmathurotsakul, D-
dc.contributor.authorOkeke, IN-
dc.contributor.authorShetty, N-
dc.contributor.authorvan Doorn, R-
dc.contributor.authorFeasey, NA-
dc.contributor.authorChiara, F-
dc.contributor.authorZoubiane, G-
dc.contributor.authorJinks, T-
dc.contributor.authorParkhill, J-
dc.contributor.authorPatel, J-
dc.contributor.authorReid, SWJ-
dc.contributor.authorHolmes, AH-
dc.contributor.authorPeacock, SJ-
dc.date.accessioned2018-10-22T07:45:43Z-
dc.date.available2018-10-22T07:45:43Z-
dc.date.issued2018-
dc.identifier.citationWellcome Open Research, 2018, v. 3, n. 59, p. 1-12-
dc.identifier.issn2398-502X-
dc.identifier.urihttp://hdl.handle.net/10722/263867-
dc.description.abstractIn recognition of the central importance of surveillance and epidemiology in the control of antimicrobial resistance and the need to strengthen surveillance at all levels, Wellcome has brought together a new international expert group SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium). SEDRIC aims to advance and transform the ways of tracking, sharing and analysing rates of infection and drug resistance, burden of disease, information on antibiotic use, opportunities for preventative measures such as vaccines, and contamination of the environment. SEDRIC will strengthen the availability of information needed to monitor and track risks, including an evaluation of access to, and utility of data generated by pharma and research activities, and will support the translation of surveillance data into interventions, changes in policy and more effective practices. Ways of working will include the provision of independent scientific analysis, advocacy and expert advice to groups, such as the Wellcome Drug Resistant Infection Priority Programme. A priority for SEDRIC's first Working Group is to review mechanisms to strengthen the generation, collection, collation and dissemination of high quality data, together with the need for creativity in the use of existing data and proxy measures, and linking to existing in-country networking infrastructure. SEDRIC will also promote the translation of technological innovations into public health solutions.-
dc.languageeng-
dc.publisherWellcome Trust . The Journal's web site is located at https://wellcomeopenresearch.org/-
dc.relation.ispartofWellcome Open Research-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectSEDRIC-
dc.subjectSurveillance-
dc.subjectAntimicrobial-
dc.subjectDrug resistant infections-
dc.subjectEpidemiology-
dc.titleSurveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action-
dc.typeArticle-
dc.identifier.emailFukuda, K: kfukuda@hku.hk-
dc.identifier.authorityFukuda, K=rp02247-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.12688/wellcomeopenres.14586.2-
dc.identifier.pmid29904730-
dc.identifier.pmcidPMC5989141-
dc.identifier.scopuseid_2-s2.0-85091221013-
dc.identifier.hkuros293690-
dc.identifier.volume3-
dc.identifier.issue59-
dc.identifier.spage1-
dc.identifier.epage12-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl2398-502X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats